MyFinsight
Home
Blog
About
Contact
Download
Download image
Depreciation and
amortization
$111,717K
Net income
$97,308K
Impairment of intangible
assets
$86,546K
Change in inventories
-$47,361K
Share-based compensation
expense
$33,827K
Other non-cash
operating activities
$10,726K
Amortization of fair value
inventory step-up
$5,814K
Net cash provided by
operating activities
$293,221K
Effect of exchange
rates on cash and cash...
$3,463K
Canceled cashflow
$100,078K
Net change in cash
and cash...
-$61,323K
Canceled cashflow
$296,684K
Proceeds from sale of
property, plant and...
$1,375K
Proceeds from revolving
facility
$300,000K
Proceeds from employee
stock purchase plan
$7,893K
Change in other assets
and other...
$35,028K
Deferred income taxes
-$26,471K
Change in accounts
payable and accrued...
-$16,571K
Change in accounts
receivable
$14,881K
Change in prepaid
income taxes
$4,534K
Remeasurement of contingent
consideration
-$1,879K
Gains on sales of
property, plant and...
$714K
Net cash used in
investing activities
-$179,547K
Canceled cashflow
$1,375K
Net cash (used in)
provided by financing...
-$178,460K
Canceled cashflow
$307,893K
Acquisitions
$60,180K
Non-cash transfers from
inventory to property,...
-$51,891K
Other investments
$36,071K
Capital expenditures
$32,780K
Repayment and repurchase
of convertible...
$300,000K
Share repurchases
$175,000K
Repayment of term loan
borrowings
$6,250K
Cash used to net share
settle employee equity...
$5,001K
Other financing
activities
-$102K
Back
Back
Cash Flow
HAEMONETICS CORP (HAE)
HAEMONETICS CORP (HAE)
source: myfinsight.com